EFFECTS OF GOKO CLEANSER DECOCTION ON SOME BIOCHEMICAL PARAMETERS OF ALBINO WISTAR RATS

  • 0 Review(s)

Product Category: Projects

Product Code: 00007267

No of Pages: 78

No of Chapters: 1-5

File Format: Microsoft Word

Price :

₦5000

  • $

ABSTRACT

This study investigated the effect of Goko cleanser on some biochemical parameters in albino wistar rats. Rats were divided into 4 groups of 5 rats each. Group I, which is the control, was given normal rat feed and water only. Group II, III and IV were administered 10ml/kg body weight, 15ml/kg body weight and 20ml/kg body weight of Goko cleanser respectively for 28 days. The result of this study showed that in Group III there was a significant (p<0.05) increase in the level of activity of the liver enzyme aspartate amino transferase (AST) (58.6±7.79 IU/I), when compared to the value of the normal group (40.70±2.49mg/l). Group IV showed significant decrease (p>0.05) in the concentration of total bilirubin (TB) (0.26±0.7 mg/l) when compared to the normal control in (0.44±0.19 mg/l). The concentration of Total Protein (TP), Alanine amino transferase (ALT), Alanine phosphatase (ALP) in Groups II, III, IV showed no significant differences when compared to the control (Group I). Group II showed significant increase (p<0.05) in the concentration of super dismutase (SOD) (3.11±1.68IU/I) when compared to the normal control (1.26± 0.95 IU/I). Group II, III, IV showed no significant difference in catalase activity when compared to the normal group. The administration of Goko cleanser to Group III had a significant increase (p<0.05) in creatinine level (1.15±0.015mg/dl) when compared to control (1.01±0.09 mg/dl) while Group IV showed significant (p>0.05) decrease in creatinine level (0.87±0.07 mg/dl) when compared to control (1.61±0.09mg/l). The concentration of urea (44.1±3.37 mg/dl) in Group IV showed significant increase (p<0.05) when compared to the normal (25.39±4.26 mg/dl).  Results obtained from this study seem to suggest that Goko cleanser may have some hepatoprotective property and may not be safe for use at high doses.  




TABLE OF CONTENTS

Cover Page                                                                                                                              i

Title Page                                                                                                                                ii

Declaration                                                                                                                              iii

Certification                                                                                                                            iv

Dedication                                                                                                                              v

Acknowledgements                                                                                                                vi

Table of Contents                                                                                                                   vii

List of Tables                                                                                                                          xi

Abstract                                                                                                                                  xii

CHAPTER 1

1.1       Introduction                                                                                                                1

1.2       Aim and Objectives                                                                                                    3

1.2.1    Aim of Study                                                                                                              3

1.2.2    Objectives of Study                                                                                                    3

1.3       Justification of the Study                                                                                           3

 

CHAPTER 2: LITERATURE REVIEW

2.1       Medicinal Plants                                                                                                         5

2.1.1    History of medicinal plants in phototherapy                                                              5

2.1.2    Importance of medicinal plants in drug discovery                                                     6

2.2       Traditional Systems of Medicine                                                                                7

2.2.1    Historical and current perspective                                                                              7

2.2.2    Asian traditional medicine                                                                                          8

2.2.3    European traditional medicine                                                                                    9

2.2.4    Neo-western traditional medicine                                                                               9

2.2.5   African traditional medicine                                                                                        9

2.3       Modern Phytomedicine                                                                                              10

2.3.1    Prospect of Modern Medicine                                                                                    10

2.3.2    Constraints in herbal medicine                                                                                    11                    

2.3.2.1  Reproducibility of biological activity of herbal extracts                                           11

2.3.2.2  Toxicity and adverse effect of plants extracts                                                           12

2.3.2.3  Adulteration and contamination                                                                                12

2.3.2.4  Herb-drug interactions                                                                                               13

2.3.2.5  Standardization of medicinal plants products                                                           18    

2.3.3    Improving the quality, safety and efficacy of herbal medicines                                19

2.3.3.1 Mediculture                                                                                                                 19

2.3.3.2  Correct identification of plant material                                                                     19

2.4        Secondary Metabolites                                                                                              20

2.5       Toxicology                                                                                                                  20

2.5.1    Methods used in toxicological studies                                                                        21

2.5.1.1  Acute toxicity test methods                                                                                       21

2.6       Hepatoxicity                                                                                                               22

2.6.1    Drug induce liver injury (DILI)                                                                                  23

2.6.1.1 Steatosis (Fatty Liver)                                                                                               23

2.6.1.2  Necrosis                                                                                                                     25

2.6.1.3  Apoptosis                                                                                                                   25

2.6.1.4  Cholestasis                                                                                                                 26

2.6.1.5 Cirrhosis                                                                                                                      26

2.6.1.6 Hepatitis                                                                                                                      26

2.7       The Biochemical Parameters                                                                                       27

2.7.1    Creatinine                                                                                                                    27

2.7.2    The total protein                                                                                                          27

2.7.3    Urea                                                                                                                            28

2.7.4    Cholesterol                                                                                                                  29

2.7.5    Triacyglecerol (TAG)                                                                                                  29

2.7.6    Malondialdehyde (Lipid Peroxidation Index)                                                                        29

2.8       Antioxidant Enzymes                                                                                                 30

2.8.1    Superoxide dismutase (SOD)                                                                                                 30

2.8.2    Catalase                                                                                                                       31

2.8.3    Glutathione peroxidase (GPX)                                                                                    31

2.8.4    Glutathione                                                                                                                 32

 

CHAPTER 3: MATERIALS AND METHODS

3.1       Materials                                                                                                                     33

3.1.1    Goko cleanser bitters                                                                                                  33

3.1.2    List of reagent                                                                                                             33

3.2       Method                                                                                                                       34

3.2.1    Animals                                                                                                                       34

3.2.2    Determination of goko cleanser dose of administration                                             34

3.2.3    Animal Feeding and Grouping                                                                                   34

3.2.4    Sample Collection                                                                                                       35

3.2.5    Determination of Aspartate Aminotransferase                                                           35

3.2.6    Determination of Alanine Aminotransferase                                                              36

3.2.7    Determination of Alkaline Phosphatase Activity                                                       36

3.2.8    Total Serum Protein Concentration                                                                              37

3.2.9    Determination of Superoxide Dismutase (SOD) activity                                           38

3.2.10  Determination of Catalase                                                                                          39

3.2.11  Malondialdehyde (Lipid perioxidation Index)                                                           39

3.2.12  Determination of cholesterol                                                                                       40

 

3.2.13  Determination of Total Triacylglycerol                                                                       40

3.2.14  High Density Lipoprotein (HDL) Cholesterol                                                            42

3.2.15 Low Density Lipoprotein (LDL) Cholesterol                                                             42

3.3.16  Determination of Creatinine                                                                                       43

3.2.17    Determination of Serum Urea                                                                                     43

3.3       Statistical Analysis                                                                                                      44

 

CHAPTER 4: RESULTS AND DISCUSSION

4.1       Results                                                                                                                        45

4.2       Discussion of Results                                                                                                  50

 

CHAPTER 5: CONCLUSION AND RECOMMENDATION

5.1       Conclusion                                                                                                                  52

5.2       Recommendations                                                                                                      52

            References                                                                                                                  53

            Appendix                                                                                                                    63




LIST OF TABLES

                                                                                                                                              Pages

2.1:                 Some of the most economically important pharmaceutical

                       and their precursors derived from plants                                                        7         

 

2.2:                 Documented reports on some medicinal plants and their

                       adverse effects                                                                                                            15

 

2.3:                 Herbal preparation – drugs interactions                                                          16

 

2.4:                 Biochemical Markers of Liver Injury                                                  23

 

3.1:                 Determination of total triacylglycerol                                                             41

 

4.1:                 Present effect of administration of Goko cleanser on Liver

                       function parameters in albino wistar rats                                                        45       

4.2:                  Effect of administration of Goko cleanser on antioxidant enzymes              46

 

 4.3:               Effect of administration of Goko cleanser on  malonialdehyde

                        (MDA) concentration in rats                                                                           47

 

4.4:                  Effect of administration of Goko cleanser on  lipid

                        profile parameters                                                                                           48

 

4.5:                  Effect of administration of Goko cleanser on  kidney

                        function   parameters                                                                                      49

 

 

 

 

  

          

 

 

CHAPTER 1

INTRODUCTION


1.1       BACKGROUND OF THE STUDY

Herbal bitters are made from herbs, these herbs are essential to phytotherapy input to holistic medicine. They generally have a bitter taste. The bitterness is often clarified as being due to a bitter principle; but this may be a volatile oil, and alkaloid or asesquiterpene (Hoffmann, 2003).  In current herbal medicine, “bitter principles” occupy a middle place in herbal therapeutics, bearing the acrid components.

Most people drinking herbal medicines complain about the bitterness of the medicines prescribed. This could be the only defining attribute of herbal medicine and the only characteristics to set it apart from other therapies (Hoffman, 2003).  Herbs stimulate a variety of liver activities mostly enhancing bile production and its discharge from the gall bladder.

 

Bitter herbs may also lead to a moderate enhancement and stimulation of endocrine activities, especially insulin and glucagon secretion by the Islets of Langerhans in the pancreas.  Therefore, diabetics need to be taken care with bitter herb as they play a role in treating the non-insulin dependent diabetes (Shivaprasad et al, 2013). All over the world, the use of organic drugs is becoming increasingly popular.  

 

Even in the developed countries, the use of organic products in the therapy of certain diseases is acceptable.  Studies have now proven that organic drugs are effective which allows for such products to be known and listed among registered drugs.  In Nigeria, it is gradually becoming fit that organic drugs can be used side by side with orthodox medicine for treating diseases. 

 

So far, all organic drugs in Nigeria are in a way known by the national regulatory agency: National Agency for Food and Drugs Administration and control (NAFDAC). Goko Cleanser belongs to the group of organic drugs and was launched into the market in 2012 by the company of Dr Iguedos. Since it was introduced into the Nigerian drug market it has been widely accepted, made use of the general public.

 

It has become a household name and there are very few reports of it adverse reaction, which may account for its wide acceptability. Goko cleanser is formulated in such a way that the ingredients have a concerted effect on the management of diseases of the digestive system. This bitter decreases the stomach acidity in the case of ulcer by diminishes the production of gastric juice (Tilburt, 2008).

 

Bitter herb also helps to stimulate the liver thereby ensuring proper and complete digestion (Finkel, 2000). It is especially effective in digesting fatty foods. It also enhances blood circulation. Goko cleanser helps to facilitate reduction in blood pressure via arteries dilation, assists in the discarding of cholesterol, sugar, triacylglycerols, secretive and uric acid.  In the nervous system, Goko cleanser promotes effective function of the secretive glands (Shivaprasad et al, 2013).

 

It is beneficial in the treatment of such disorders as insomnia, stress and depression.  In the urinary and excretory systems; it facilitates the process of ultra filtration by the nephrone, it also helps in the dissolution and prevention of kidney stones and bladder infections. It is also useful in regulating the proper operation of the intestines by preventing constipation. In ulcerations, Goko cleanser inhibits the formation of ulcers by eliminating any traces of stored toxins in the body and aids in immune boosting (Ribnicky et al, 2008). It prevents hardening of tissues by dissolving materials which are toxic, and also promotes cell formation and development (Qi et al, 2013). Goko bitter prevents overweight and encourages healthy weight loss (Chandrasekaran et al., 2012).

 

1.2       AIM AND OBJECTIVES

1.2.1    Aim of study

The aim of the study is to determine the effect of Goko cleanser decoction on some biochemical parameters of Albino Wistar Rats  

 

1.2.2    Objectives

The objective of this study is to determine biochemical effects of Goko Cleanser decoction on Albino Wistar Rats using the parameters listed below:

 

·         Liver function markers including Aspartate transaminase activity, alanine transaminase, alanine phosphatase, total protein and  total bilirubin

·         Antioxidant enzymes Activity including  Superoxide dimutase and catalase

·         Concentration of Malondialdehyde

·         Lipid profile including Cholesterol, triacylglycerol, high density lipoprotein, very low density lipoprotein and low density lipoprotein

·         Kidney function including creatinine and urea

 

 

1.3       JUSTIFICATION OF THE STUDY

Herbal bitters include finished labeled products as the active ingredient. Goko cleansers have been verified by pharmacological and clinical evaluations and are generally used as alternative medicine in health care. Herbal formulation remains as part of primary health care in many African counties and also an integral component of complementary and alternative medicine the entire world over (Okigbo and Emeka, 2006; Barbosa et al., 2012).

 

The World Health Organization (WHO) estimates that as much as 80% of   people in African countries used herbal medicine to augment their primary health care (Zhou et al., 2004).

 

Among the major defect which includes poor dosage formation and standardization of the products (Okigbo and Emeka, 2006; Calixto, 2000). Considering the fact that Goko cleanser is used in the treatment of several diseases, it is necessary to ascertain the biochemical effect of it.

 

Click “DOWNLOAD NOW” below to get the complete Projects

FOR QUICK HELP CHAT WITH US NOW!

+(234) 0814 780 1594

Buyers has the right to create dispute within seven (7) days of purchase for 100% refund request when you experience issue with the file received. 

Dispute can only be created when you receive a corrupt file, a wrong file or irregularities in the table of contents and content of the file you received. 

ProjectShelve.com shall either provide the appropriate file within 48hrs or send refund excluding your bank transaction charges. Term and Conditions are applied.

Buyers are expected to confirm that the material you are paying for is available on our website ProjectShelve.com and you have selected the right material, you have also gone through the preliminary pages and it interests you before payment. DO NOT MAKE BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.

In case of payment for a material not available on ProjectShelve.com, the management of ProjectShelve.com has the right to keep your money until you send a topic that is available on our website within 48 hours.

You cannot change topic after receiving material of the topic you ordered and paid for.

Ratings & Reviews

0.0

No Review Found.


To Review


To Comment